This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Biopsy Device Market

Market Insights on Biopsy Device covering sales outlook, demand forecast & up-to-date key trends

Biopsy Device Market by Product Type (Guidance System, Needles, Guns, Reagents and Kits), Application (Medical Diagnosis, Scientific Research) End User, & Region - Forecast to 2021-2031

Biopsy Device Market Snapshot

Biopsy device sales is expected to reach US$ 3089.2 Mn by the end of 2031. The market is set to register a CAGR of 5.2% between 2021 and 2031.

Needle-based biopsy will continue as the top-selling product category, accounting for nearly one-third of global demand by 2031. Rising use of needle-based biopsy for extracting fluid or tissue from a suspicious lump or any other abnormal area of the body will guarantee increasing sales in the segment.

Regionally, North America biopsy device market will hold the dominant share 34% by 2021 owing to rising prevalence of cancer and favorable reimbursement scenario.

Customize this Report

Let us know your requirement to get
100% FREE customization

Biopsy Device Market - Key Points Covered in Study

  • Biopsy Device Market Estimates and Forecast 2016-2031
  • Key Drivers and Restraints Impacting Market Growth
  • Segment-wise, Country-wise, and Region-wise Analysis
  • Competition Mapping and Benchmarking
  • Brand share and Market Share Analysis
  • Key Product Innovations and Regulatory Climate
  • COVID-19 Impact on Biopsy Device Market and How to Navigate
  • Recommendation on Key Winning Strategies

Biopsy Device Market Download Report Brochure

Biopsy Device Market Demand Outlook in Comparison to 2021-2031 Forecast

The global biopsy device market is estimated to be worth US$ 1862.6 Mn in 2021. The market is forecast to grow at a CAGR of 5.2% between 2021 and 2031, reaching a valuation of US$ 3,089.2 Mn by the end of 2031.

The robust growth of market can be attributed to the increasing incidence of cancer, favorable reimbursement programs, and shift towards minimally invasive procedures. Rising patient pool is encouraging the development of more advanced, effective, and safe biopsy procedures.

According to World Health Organization (WHO), cancer accounted for nearly 10 million deaths in 2020. Rising prevalence of various cancers such as breast cancer, lung cancer and leukemia is positively impacting the demand outlook for biopsy devices.

Various initiatives undertaken by governments and healthcare organizations regarding cancer treatment and diagnosis will accelerate the market growth further during the forecast period. Similarly, increasing healthcare expenditure and extensive research and development (R&D) activities are positively influencing the market.

Rapid technological advancements such as Vaccuum assisted guns, 3D optical biopsies, MRI-targeted biopsies and Ultrasound-guided biopsies are fueling the adoption of biopsy devices. As biopsy procedure can be performed for almost any organ with accurate diagnosis, more people are opting for it.

Key companies operating in the biopsy device market are focusing on organic growth strategies such as product launches and product approvals. They have adopted various strategies such as mergers and acquisitions, advanced product development and collaborations to gain a competitive edge in the market.

For instance, in 2021 Biocept, Inc. announced collaboration with Quest Diagnostics to offer laboratory testing services to patients in Quest for its Target Selectortm NGS-based liquid biopsy targeted lung cancer panel.

Similarly, in October 2020 GE Healthcare announced the launch of its new Serena Bright biopsy technology in the U.S. The Serena Bright biopsy solution is particularly designed to offer advanced breast cancer diagnosis and treatment.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Government initiatives in cancer treatment to fuel Biopsy Device Market growth

Global demand for biopsy devices is increasing, supported by rising incidence of cancer. Future Market Insights presents in-depth analysis of the global biopsy device market for the forecast period, 2021-2031. Revenue from the global market is expected to register a CAGR of around 5.2% during the assessment period and is expected to be valued at nearly US$ 3,089.2 Mn by 2031 end.

Increasing incidence of cancer and favorable reimbursement programs set to drive growth for Biopsy Device Market

The guidance system segment was estimated to account for 16.1% revenue share of the global biopsy device market by 2021 end and is expected to gain 222 BPS in market share by 2031 over 2021, owing to an increase in the awareness of early detection of breast cancer.

The needles segment will hold nearly one-third of the global biopsy device market by 2031 end and is expected to lose 125 BPS in market share by 2031 over 2021. The segment is expected to surpass US$ 960 Mn by 2031 owing to an increasing awareness among people regarding the early detection of cancer.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Biopsy Device Market Absolute $ Opportunity by Product Type, 2021–2031

Guidance system segment is estimated to create absolute $ opportunity of more than US$ 15 Mn in 2021. Revenue from guidance system segment is anticipated to register a CAGR of 7.9% over the forecast period, reaching a market valuation of around US$ 480 Mn by the end of 2031.

  • Biopsy needles segment is estimated to create absolute $ opportunity of around US$ 30 Mn in 2021. Revenue from biopsy needles segment is anticipated to register a CAGR of 6.2% over 2021–2031, surpassing US$ 960 Mn by 2031 end.
  • Guns segment is estimated to create absolute $ opportunity of around US$ 25 Mn in 2021. Revenue from guns segment is anticipated to witness a CAGR of 6.8% during the forecast period, surpassing US$ 700 Mn towards the close of 2031
  • Reagents and kits segment is estimated to create absolute $ opportunity of more than US$ 3 Mn in 2021. Revenue from reagents and kits segment is anticipated to witness a CAGR of 6.4% over 2021–2031, to reach nearly US$ 120 Mn at the end of the assessment period
  • Others (Brushes, Curettes and Punches etc.) segment is estimated to create absolute $ opportunity of nearly US$ 10 Mn in 2021. Revenue from Others segment is anticipated to witness a CAGR of 5.3% over 2021–2031, to reach more than US$ 360 Mn by 2031 end.

Biopsy Device Market Attractiveness Analysis by Product Type, 2021–2031

Needles segment dominated the global biopsy device market in revenue terms in 2020 and is projected to continue to do so throughout the forecast period. Needles segment is the most attractive segment, with a market attractiveness index of 1.8 over the forecast period. The segment accounted for 37.7% value share in 2021 and is projected to account for around 36.5% share by 2031 end.

Guns segment is expected to be the second most lucrative segment in the global biopsy device market, with a market attractiveness index of 1.3 during the forecast period. The increasing requirement for more advanced and innovative technology products in the field of biopsy and growing usage of biopsy needles makes it the most attractive segment in the global biopsy device market.

Biopsy Device Market - Competitive Landscape

Companies operating in the global biopsy device market are actively engaged in mergers, acquisitions and partnerships to capture a larger share of the market in the near future.

The global biopsy device market is a fragmented market with about 69% market share contributed by CR Bard, Becton, Dickinson and Company, B. Braun Melsungen AG, Hologic, Inc., Cook Medical, Devicor Medical Products Inc. and Argon Medical Inc. Companies are entering into strategic mergers and acquisitions to improve their biopsy device product portfolio and are focussing on distributional agreements to overcome issues related to product availability in various geographical areas.

Biopsy Device Market - Analyst Viewpoint

“In the coming decade, liquid biopsy procedure is likely to pose a major threat to the biopsy device market”

Liquid biopsy offers non-invasive diagnostic tests for detecting cancer as it provides a simple, relatively less expensive blood, urine or plasma test to detect malignancy in any part of the patient’s body. Liquid biopsy is expected to provide a better sample for any type of diagnosis and analysis as it can be taken repeatedly. This overcomes the challenge associated with repeated tissue samples. Liquid samples help detect disease progression in real time, predict outcomes and switch treatment when required and potentially increase the life expectancy of the patient. Thus, liquid biopsy procedure is likely to be a major threat to the global biopsy device market in the coming decade.

Biopsy Device Market - Market Segmentation

By Product Type:

  • Guidance System
    • Stereotactic X-Ray Guided Biopsy
    • Ultrasound Guided Biopsy
    • MRI Guided Biopsy
  • Needles
    • Core Needles
    • Fine Aspiration Needles
  • Guns
  • Reagents and Kits
  • Others (Brushes, Curettes and Punches etc.)

By Application:

  • Medical Diagnosis
  • Scientific Research

By End Use:

  • Hospital
  • Specialised Oncology Centres
  • Diagnostic Centres
  • Research Institutes

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • MEA

Frequently Asked Questions

The global biopsy device market is estimated to be worth US$ 1862.6 Mn in 2021.

The biopsy device market is expected to grow at a CAGR of 5.2% between 2021 and 2031, reaching a market valuation of 3,089.2 Mn by the end of 2031.

The Biopsy device market grew at 7.4% CAGR in the last five years, from 2016 to 2020.

Increasing collaboration of government and private medical companies and rapid utilization of biopsy devices for monitoring the diseases are some of the key trends prevailing in biopsy device market.

Increasing prevalence of cancer, favorable reimbursement scenario and rising preference for minimally invasive procedures are some of the factors driving the biopsy device market.

The combined share of top 5 players is around 25-30% of the overall market.

As per FMI analysis, North America accounted for nearly 34% market share in global devices market during 2021.

 Germany is leading the market for biopsy devices in Europe with a share of around 28%.

The countries like China, Germany, Japan, U.K and the U.S. are witnessing huge demand for biopsy devices.

Japan and South Korea cumulatively account for 8.4% share in global biopsy device market.

Table of Content

1.  Executive Summary

2.  Market Introduction

2.1. Market Definition

2.2. Market Taxonomy

2.3. Parent / Associated Market Overview

3.  Global Biopsy Device Analysis Scenario

3.1. Pricing Analysis

3.1.1. Pricing Assumptions

3.1.2. Price Projections Per Region

3.2. Market Size (US$ Mn) and Forecast

3.2.1. Market Size and Y-o-Y Growth

3.2.2. Absolute $ Opportunity

3.3. Market Overview

3.3.1. Value Chain

4.  Market Dynamics

4.1. Macro-economic Factors

4.2. Drivers

4.2.1. Supply Side

4.2.2. Demand Side

4.3. Restraints

4.4. Opportunity

4.5. Forecast Factors – Relevance and Impact

4.6. Global Incidence of Cancer

4.7. Global Trends

5. Global Biopsy Device Analysis and Forecasts, By Product 

5.1. Introduction

5.2. Basis Point Share (BPS) Analysis By Product Type

5.3. Y-o-Y Growth Projections By Product Type

5.4. Market Value and Volume Forecast By Product, 2016–2026

5.4.1. Guidance System

5.4.1.1. Stereotactic X-Ray Guided Biopsy

5.4.1.2. Ultrasound Guided Biopsy

5.4.1.3. MRI Guided Biopsy

5.4.2. Needles

5.4.2.1. Core Needle

5.4.2.2. Fine Aspiration Needles

5.4.3. Guns

5.4.4. Reagents and Kits

5.4.5. Others (Brushes, Curettes and Punches etc.)

5.5. Market Attractiveness By Product 

6. Global Biopsy Device Analysis and Forecasts, By Application 

6.1. Introduction

6.2. Basis Point Share (BPS) Analysis By Application 

6.3. Y-o-Y Growth Projections By Application 

6.4. Market Value Forecast By Application, 2016–2026

6.4.1. Scientific Research

6.4.2. Medical Diagnostics

6.5. Market Attractiveness By Application 

7. Global Biopsy Device Analysis and Forecasts, By End Users 

7.1. Introduction

7.2. Basis Point Share (BPS) Analysis By End Users 

7.3. Y-o-Y Growth Projections By End Users 

7.4. Market Value Forecast By End Users, 2016–2026

7.4.1. Hospitals

7.4.2. Specialized Oncology Centers

7.4.3. Diagnostic Centers

7.4.4. Research Institutes

7.5. Market Attractiveness By End Users 

8. Global Biopsy Device Analysis and Forecasts, By Region

8.1. Basis Point Share (BPS) Analysis By Region

8.2. Y-o-Y Growth Projections By Region

8.3. Market Value Forecast By Region

8.3.1. North America 

8.3.2. Latin America 

8.3.3. Western Europe 

8.3.4. Eastern Europe 

8.3.5. APEJ 

8.3.6. Japan 

8.3.7. MEA 

8.4. Market Attractiveness By Region

9. North America Biopsy Device Analysis and Forecast

9.1. Introduction

9.1.1. Basis Point Share (BPS) Analysis By Country

9.1.2. Y-o-Y Growth Projections By Country

9.1.3. Key Regulations

9.2. Market Value and Volume Forecast By Product, 2016–2026

9.2.1. Guidance System

9.2.1.1. Stereotactic X-Ray Guided Biopsy

9.2.1.2. Ultrasound Guided Biopsy

9.2.1.3. MRI Guided Biopsy

9.2.2. Needles

9.2.2.1. Core Needle

9.2.2.2. Fine Aspiration Needles

9.2.3. Guns

9.2.4. Reagents and Kits

9.2.5. Others (Brushes, Curettes and Punches etc.)

9.3. Market Value Forecast By Application, 2016–2026

9.3.1. Scientific Research

9.3.2. Medical Diagnostics

9.4. Market Value Forecast By End Users, 2016–2026

9.4.1. Hospitals

9.4.2. Specialized Oncology Centers

9.4.3. Diagnostic Centers

9.4.4. Research Institutes

9.5. Market Value Forecast By Country, 2016–2026

9.5.1. US

9.5.2. Canada

9.6. Market Attractiveness Analysis 

9.6.1. By Product 

9.6.2. By Application 

9.6.3. By End Users 

9.6.4. By Country

10. Latin America Biopsy Device Analysis and Forecast

10.1.Introduction

10.1.1. Basis Point Share (BPS) Analysis By Country

10.1.2. Y-o-Y Growth Projections By Country

10.1.3. Key Regulations

10.2.Market Value and Volume Forecast By Product, 2016–2026

10.2.1. Guidance System

10.2.1.1. Stereotactic X-Ray Guided Biopsy

10.2.1.2. Ultrasound Guided Biopsy

10.2.1.3. MRI Guided Biopsy

10.2.2. Needles

10.2.2.1. Core Needle

10.2.2.2. Fine Aspiration Needles

10.2.3. Guns

10.2.4. Reagents and Kits

10.2.5. Others (Brushes, Curettes and Punches etc.)

10.3.Market Value Forecast By Application, 2016–2026

10.3.1. Scientific Research

10.3.2. Medical Diagnostics

10.4.Market Value Forecast By End Users, 2016–2026

10.4.1. Hospitals

10.4.2. Specialized Oncology Centers

10.4.3. Diagnostic Centers

10.4.4. Research Institutes

10.5.Market Value Forecast By Country, 2016–2026

10.5.1. Argentina

10.5.2. Brazil

10.5.3. Mexico

10.5.4. Rest of Latin America

10.6.Market Attractiveness Analysis 

10.6.1. By Product 

10.6.2. By Application 

10.6.3. By End Users 

10.6.4. By Country

11. Western Europe Biopsy Device Analysis and Forecast

11.1.Introduction

11.1.1. Basis Point Share (BPS) Analysis By Country

11.1.2. Y-o-Y Growth Projections By Country

11.1.3. Key Regulations

11.2.Market Value and Volume Forecast By Product, 2016–2026

11.2.1. Guidance System

11.2.1.1. Stereotactic X-Ray Guided Biopsy

11.2.1.2. Ultrasound Guided Biopsy

11.2.1.3. MRI Guided Biopsy

11.2.2. Needles

11.2.2.1. Core Needle

11.2.2.2. Fine Aspiration Needles

11.2.3. Guns

11.2.4. Reagents and Kits

11.2.5. Others (Brushes, Curettes and Punches etc.)

11.3.Market Value Forecast By Application, 2016–2026

11.3.1. Scientific Research

11.3.2. Medical Diagnostics

11.4.Market Value Forecast By End Users, 2016–2026

11.4.1. Hospitals

11.4.2. Specialized Oncology Centers

11.4.3. Diagnostic Centers

11.4.4. Research Institutes

11.5.Market Value Forecast By Country, 2016–2026

11.5.1. UK

11.5.2. France

11.5.3. Germany

11.5.4. Italy

11.5.5. Spain

11.5.6. Nordic

11.5.7. Benelux

11.5.8. Rest of Western Europe

11.6.Market Attractiveness Analysis 

11.6.1. By Product 

11.6.2. By Application 

11.6.3. By End Users 

11.6.4. By Country

12. Eastern Europe Biopsy Device Analysis and Forecast

12.1.Introduction

12.1.1. Basis Point Share (BPS) Analysis By Country

12.1.2. Y-o-Y Growth Projections By Country

12.1.3. Key Regulations

12.2.Market Value and Volume Forecast By Product, 2016–2026

12.2.1. Guidance System

12.2.1.1. Stereotactic X-Ray Guided Biopsy

12.2.1.2. Ultrasound Guided Biopsy

12.2.1.3. MRI Guided Biopsy

12.2.2. Needles

12.2.2.1. Core Needle

12.2.2.2. Fine Aspiration Needles

12.2.3. Guns

12.2.4. Reagents and Kits

12.2.5. Others (Brushes, Curettes and Punches etc.)

12.3.Market Value Forecast By Application, 2016–2026

12.3.1. Scientific Research

12.3.2. Medical Diagnostics

12.4.Market Value Forecast By End Users, 2016–2026

12.4.1. Hospitals

12.4.2. Specialized Oncology Centers

12.4.3. Diagnostic Centers

12.4.4. Research Institutes

12.5.Market Value Forecast By Country, 2016–2026

12.5.1. Russia

12.5.2. Poland

12.5.3. Rest of Eastern Europe

12.6.Market Attractiveness Analysis 

12.6.1. By Product 

12.6.2. By Application 

12.6.3. By End Users 

12.6.4. By Country

13. APEJ Biopsy Device Analysis and Forecast

13.1.Introduction

13.1.1. Basis Point Share (BPS) Analysis By Country

13.1.2. Y-o-Y Growth Projections By Country

13.1.3. Key Regulations

13.2.Market Value and Volume Forecast By Product, 2016–2026

13.2.1. Guidance System

13.2.1.1. Stereotactic X-Ray Guided Biopsy

13.2.1.2. Ultrasound Guided Biopsy

13.2.1.3. MRI Guided Biopsy

13.2.2. Needles

13.2.2.1. Core Needle

13.2.2.2. Fine Aspiration Needles

13.2.3. Guns

13.2.4. Reagents and Kits

13.2.5. Others (Brushes, Curettes and Punches etc.)

13.3.Market Value Forecast By Application, 2016–2026

13.3.1. Scientific Research

13.3.2. Medical Diagnostics

13.4.Market Value Forecast By End Users, 2016–2026

13.4.1. Hospitals

13.4.2. Specialized Oncology Centers

13.4.3. Diagnostic Centers

13.4.4. Research Institutes

13.5.Market Value Forecast By Country, 2016–2026

13.5.1. China

13.5.2. India

13.5.3. Australia & New Zealand

13.5.4. ASEAN

13.5.5. Rest of APEJ

13.6.Market Attractiveness Analysis 

13.6.1. By Product 

13.6.2. By Application 

13.6.3. By End Users 

13.6.4. By Country

14. Japan Biopsy Device Analysis and Forecast

14.1.Introduction

14.1.1. Basis Point Share (BPS) Analysis By Country

14.1.2. Y-o-Y Growth Projections By Country

14.1.3. Key Regulations

14.2.Market Value and Volume Forecast By Product, 2016–2026

14.2.1. Guidance System

14.2.1.1. Stereotactic X-Ray Guided Biopsy

14.2.1.2. Ultrasound Guided Biopsy

14.2.1.3. MRI Guided Biopsy

14.2.2. Needles

14.2.2.1. Core Needle

14.2.2.2. Fine Aspiration Needles

14.2.3. Guns

14.2.4. Reagents and Kits

14.2.5. Others (Brushes, Curettes and Punches etc.)

14.3.Market Value Forecast By Application, 2016–2026

14.3.1. Scientific Research

14.3.2. Medical Diagnostics

14.4.Market Value Forecast By End Users, 2016–2026

14.4.1. Hospitals

14.4.2. Specialized Oncology Centers

14.4.3. Diagnostic Centers

14.4.4. Research Institutes

14.5.Market Attractiveness Analysis 

14.5.1. By Product 

14.5.2. By Application 

14.5.3. By End Users 

15. MEA Biopsy Device Analysis and Forecast

15.1.Introduction

15.1.1. Basis Point Share (BPS) Analysis By Country

15.1.2. Y-o-Y Growth Projections By Country

15.1.3. Key Regulations

15.2.Market Value and Volume Forecast By Product, 2016–2026

15.2.1. Guidance System

15.2.1.1. Stereotactic X-Ray Guided Biopsy

15.2.1.2. Ultrasound Guided Biopsy

15.2.1.3. MRI Guided Biopsy

15.2.2. Needles

15.2.2.1. Core Needle

15.2.2.2. Fine Aspiration Needles

15.2.3. Guns

15.2.4. Reagents and Kits

15.2.5. Others (Brushes, Curettes and Punches etc.)

15.3.Market Value Forecast By Application, 2016–2026

15.3.1. Scientific Research

15.3.2. Medical Diagnostics

15.4.Market Value Forecast By End Users, 2016–2026

15.4.1. Hospitals

15.4.2. Specialized Oncology Centers

15.4.3. Diagnostic Centers

15.4.4. Research Institutes

15.5.Market Value Forecast By Country, 2016–2026

15.5.1. GCC Countries

15.5.2. South Africa

15.5.3. North Africa

15.5.4. Rest of MEA

15.6.Market Attractiveness Analysis 

15.6.1. By Product 

15.6.2. By Application 

15.6.3. By End Users 

15.6.4. By Country

16. Competition Landscape

16.1. Competition Dashboard

16.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

16.2.1. Becton, Dickinson and Company 

16.2.2. Argon Medical Inc. 

16.2.3. B. Braun Melsungen AG 

16.2.4. Boston Scientific Inc. 

16.2.5. C. R. Bard, Inc. 

16.2.6. Hologic, Inc. 

16.2.7. Cook Medical 

16.2.8. INRAD Inc. 

16.2.9. Devicor Medical Products Inc. 

16.2.10. PLANMED OY

17. Assumptions and Acronyms Used

18. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Biopsy Device Market, Global Incidence of Cancer, 2012 

Table 02: Global Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 03: Global Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 04: Global Biopsy Device Volume, By Product Type, 2016 - 2026

Table 05: Global Biopsy Device Market Value, By Application, 2016 - 2026

Table 06: Global Biopsy Device Market Value, By End Users, 2016 - 2026

Table 07: Global Biopsy Device Market Value, By Region, 2016 - 2026

Table 08: North America Biopsy Device Market Value, By Country, 2016 - 2026

Table 09: North America Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 10: North America Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 11: North America Biopsy Device Volume, By Product Type, 2016 - 2026

Table 12: North America Biopsy Device Market Value, By Application, 2016 - 2026

Table 13: North America Biopsy Device Market Value, By End Users, 2016 - 2026

Table 14: Latin America Biopsy Device Market Value (%) By Country, 2016 - 2026

Table 15: Latin America Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 16: Latin America Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 17: Latin America Biopsy Device Volume, By Product Type, 2016 - 2026

Table 18: Latin America Biopsy Device Market Value, By Application, 2016 - 2026

Table 19: Latin America Biopsy Device Market Value, By End Users, 2016 - 2026

Table 20: Western Europe Biopsy Device Market Value By Country, 2016 - 2026

Table 21: Western Europe Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 22: Western Europe Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 23: Western Europe Biopsy Device Volume, By Product Type, 2016 - 2026

Table 24: Western Europe Biopsy Device Market Value, By Application, 2016 - 2026

Table 25: Western Europe Biopsy Device Market Value, By End Users, 2016 - 2026

Table 26: Western Europe Biopsy Device Market Value, By Country, 2016 - 2026

Table 27: Eastern Europe Biopsy Device Market Value, By Country, 2016 - 2026

Table 28: Eastern Europe Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 29: Eastern Europe Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 30: Eastern Europe Biopsy Device Volume, By Product Type, 2016 - 2026

Table 31: Eastern Europe Biopsy Device Market Value, By Application, 2016 - 2026

Table 32: Eastern Europe Biopsy Device Market Value, By End Users, 2016 - 2026

Table 33: APEJ Biopsy Device Market Value, By Country, 2016 - 2026

Table 34: APEJ Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 35: APEJ Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 36: APEJ Biopsy Device Volume, By Product Type, 2016 - 2026

Table 37: APEJ Biopsy Device Market Value, By Application, 2016 - 2026

Table 38: APEJ Biopsy Device Market Value, By End Users, 2016 - 2026

Table 39: Japan Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 40: Japan Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 41: Japan Biopsy Device Volume, By Product Type, 2016 - 2026

Table 42: Japan Biopsy Device Market Value, By Application, 2016 - 2026

Table 43: Japan Biopsy Device Market Value, By End Users, 2016 - 2026

Table 44: MEA Biopsy Device Market Value, By Country, 2016 - 2026

Table 45: MEA Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 46: MEA Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 47: Japan Biopsy Device Volume, By Product Type, 2016 - 2026

Table 48: MEA Biopsy Device Market Value By Application, 2016 - 2026

Table 49: MEA Biopsy Device Market Value By End Users, 2016 - 2026

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Biopsy Device Market Share, by Application Type, 2016 (E)

Figure 2: Biopsy Device Market Share, by Product Type, 2016 (E)

Figure 3: Biopsy Device Market Share, by End User, 2016 (E)

Figure 4:  Global Guidance System, Price Difference (US$) By Region, 2015

Figure 5: Global Guidance System, Price Difference (US$) By Region, 2026

Figure 6:  Global Biopsy Needles, Price Difference (US$) By Region, 2015

Figure 7:  Global Biopsy Needles, Price Difference (US$) By Region, 2026

Figure 8:  Global Biopsy Guns, Price Difference (US$) By Region, 2015

Figure 9:  Global Biopsy Guns, Price Difference (US$) By Region, 2026

Figure 10:  Global Others, Price Difference (US$) By Region, 2015

Figure 11:  Global Others, Price Difference (US$) By Region, 2026

Figure 12:  Global Biopsy Kits and Reagents, Price Difference (US$) By Region, 2015

Figure 13:  Global Biopsy Kits and Reagents, Price Difference (US$) By Region, 2026

Figure 14: Global Biopsy Device Market Share Analysis (%) By Product Type, 2016 & 2026

Figure 15: Global Biopsy Device Y-o-Y growth (%) By Product Type, 2015–2026

Figure 16: Global Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guidance System Segment, 2016–2026

Figure 17: Global Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Biopsy Needles Segment, 2016–2026

Figure 18: Global Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guns Segment, 2016–2026

Figure 19: Global Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Reagents and Kits Segment, 2016–2026

Figure 20: Global Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2016–2026

Figure 21: Global Biopsy Device Market Attractiveness Analysis by Product Type, 2016–2026

Figure 22: Global Biopsy Device Market Share Analysis (%) By Application, 2016 & 2026

Figure 23: Global Biopsy Device Y-o-Y growth (%) By Application, 2015–2026

Figure 24: Global Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Medical Diagnostic Segment, 2016–2026

Figure 25: Global Biopsy Device Market Absolute $  Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 26: Global Biopsy Device Market Attractiveness Analysis By Application, 2016–2026

 Figure 27: Global Biopsy Device Market Share Analysis (%) By Application, 2016 & 2026

Figure 28: Global Biopsy Device Y-o-Y growth (%) By End Users, 2015–2026

Figure 29: Global Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Hospital Segment, 2016–2026

Figure 30: Global Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Specialized Oncology Center Segment, 2016–2026

Figure 31: Global Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Diagnostic centers Segment, 2016–2026

Figure 32: Global Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 33: Global Biopsy Device Market Attractiveness Analysis By End Users, 2016–2026

 Figure 34: Global Biopsy Device Market Share Analysis (%) By Region, 2016 & 2026

Figure 35: Global Biopsy Device Y-o-Y growth (%) By Region 2015–2026

Figure 36: Global Biopsy Device Market Attractiveness Analysis By End Users, 2016–2026

 Figure 37: North America Biopsy Device Market Share Analysis (%) By Country, 2016 & 2026

Figure 38: North America Biopsy Device Y-o-Y growth (%) By Country 2015–2026

Figure 39: North America Biopsy Device Market Attractiveness Analysis By Country, 2016–2026

Figure 40: North America Biopsy Device Market Share Analysis (%) By Product Type, 2016 & 2026

Figure 41: North America Biopsy Device Y-o-Y growth (%) By Product Type, 2015–2026

Figure 42: North America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guidance System Segment, 2016–2026

Figure 43: North America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Biopsy Needles Segment, 2016–2026

Figure 44: North America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guns Segment, 2016–2026

Figure 45: North America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Reagents and Kits Segment, 2016–2026

Figure 46: North America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2016–2026

Figure 47: North America Biopsy Device Market Attractiveness Analysis By Product Type, 2016–2026

Figure 48: North America Biopsy Device Market Share Analysis (%) By Application, 2016 & 2026

Figure 49: North America Biopsy Device Y-o-Y growth (%) By Application, 2015–2026

Figure 50: North America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Medical Diagnostic Segment, 2016–2026

Figure 51: North America Biopsy Device Market Absolute $  Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 52: North America Biopsy Device Market Attractiveness Analysis By Application, 2016–2026

Figure 53: North America Biopsy Device Market Share Analysis (%) By End Users, 2016 & 2026

Figure 54: North America Biopsy Device Y-o-Y growth (%) By End Users, 2015–2026

Figure 55: North America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Hospital Segment, 2016–2026

Figure 56: North America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Specialized Oncology Center Segment, 2016–2026

Figure 57: North America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Diagnostic Centers Segment, 2016–2026

Figure 58: North America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 59: North America Biopsy Device Market Attractiveness Analysis By End Users, 2016–2026

 Figure 60: Latin America Biopsy Device Market Share Analysis (%) By Country, 2016 & 2026

Figure 61: Latin America Biopsy Device Y-o-Y growth (%) By Country 2015–2026

Figure 62: Latin America Biopsy Device Market Attractiveness Analysis By Country, 2016–2026

Figure 63: Latin America Biopsy Device Market Share Analysis (%) By Product Type, 2016 & 2026

Figure 64: Latin America Biopsy Device Y-o-Y growth (%) By Product Type, 2015–2026

Figure 65: Latin America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guidance System Segment, 2016–2026

Figure 66: Latin America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Biopsy Needles Segment, 2016–2026

Figure 67: Latin America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guns Segment, 2016–2026

Figure 68: Latin America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Reagents and Kits Segment, 2016–2026

Figure 69: Latin America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2016–2026

Figure 70: Latin America Biopsy Device Market Attractiveness Analysis By Product Type, 2016–2026

Figure 71: Latin America Biopsy Device Market Share Analysis (%) By Application, 2016 & 2026

Figure 72: Latin America Biopsy Device Y-o-Y growth (%) By Application, 2015–2026z

Figure 73: North America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Medical Diagnostic Segment, 2016–2026

Figure 74: North America Biopsy Device Market Absolute $  Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 75: Latin America Biopsy Device Market Attractiveness Analysis By Application, 2016–2026

Figure 76: Latin America Biopsy Device Market Share Analysis (%) By End Users, 2016 & 2026

Figure 77: Latin America Biopsy Device Y-o-Y growth (%) By End Users, 2015–2026

Figure 78: Latin America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Hospital Segment, 2016–2026

Figure 79: Latin America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Specialized Oncology Center Segment, 2016–2026

Figure 80: Latin America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Diagnostic centers Segment, 2016–2026

Figure 81: Latin America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 82: Latin America Biopsy Device Market Attractiveness Analysis By End Users, 2016–2026

Figure 83: Western Europe  Biopsy Device Y-o-Y growth (%) By Country, 2015–2026

Figure 84: Western Europe  Biopsy Device Y-o-Y growth (%) By Country, 2015–2026

Figure 85: Western Europe  Biopsy Device Market Attractiveness Analysis By Country, 2016–2026

Figure 86: Western Europe Biopsy Device Market Share Analysis (%) By Product Type, 2016 & 2026

Figure 87: Western Europe Biopsy Device Y-o-Y growth (%) By Product Type, 2015–2026

Figure 88: Western Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guidance System Segment, 2016–2026

Figure 89: Western Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Biopsy Needles Segment, 2016–2026

Figure 90: Western Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guns Segment, 2016–2026

Figure 91: Western Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Reagents and Kits Segment, 2016–2026

Figure 92: Western Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2016–2026

Figure 93: Western Europe Biopsy Device Market Attractiveness Analysis By Product Type, 2016–2026

Figure 94: Western Europe Biopsy Device Market Share Analysis (%) By Application, 2016 & 2026

Figure 95: Western Europe Biopsy Device Y-o-Y growth (%) By Application, 2015–2026

Figure 96: Western Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Medical Diagnostic Segment, 2016–2026

Figure 97: Western Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 98: Western Europe Biopsy Device Market Attractiveness Analysis by Application, 2016–2026

Figure 99: Western Europe Biopsy Device Market Share Analysis (%) By End Users, 2016 & 2026

Figure 100: Western Europe Biopsy Device Y-o-Y growth (%) By End Users, 2015–2026

Figure 101: Western Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Hospital Segment, 2016–2026

Figure 102: Western Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Specialized Oncology Center Segment, 2016–2026

Figure 103: Western Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Diagnostic centers Segment, 2016–2026

Figure 104: Western Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 105: Western Europe Biopsy Device Market Attractiveness Analysis By End Users, 2016–2026

Figure 106: Eastern Europe Biopsy Device Y-o-Y growth (%) By Country, 2015–2026

Figure 107: Eastern Europe  Biopsy Device Y-o-Y growth (%) By Country, 2015–2026

Figure 108: Eastern Europe Biopsy Device Market Attractiveness Analysis By Country, 2016–2026

Figure 109: Eastern Europe Biopsy Device Market Share Analysis (%) By Product Type, 2016 & 2026

Figure 110: Eastern Europe Biopsy Device Y-o-Y growth (%) By Product Type, 2015–2026

Figure 111: Eastern Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guidance System Segment, 2016–2026

Figure 112: Eastern Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Biopsy Needles Segment, 2016–2026

Figure 113: Eastern Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guns Segment, 2016–2026

Figure 114: Eastern Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Reagents and Kits Segment, 2016–2026

Figure 115: Eastern Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2016–2026

Figure 116: Eastern Europe Biopsy Device Market Attractiveness Analysis By Product Type, 2016–2026

Figure 117: Eastern Europe Biopsy Device Market Share Analysis (%) By Application, 2016 & 2026

Figure 118: Eastern Europe Biopsy Device Y-o-Y growth (%) By Application, 2015–2026

Figure 119: Eastern Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Medical Diagnostic Segment, 2016–2026

Figure 120: Eastern Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 121: Eastern Europe Biopsy Device Market Attractiveness Analysis By Application, 2016–2026

Figure 122: Eastern Europe Biopsy Device Market Share Analysis (%) By End Users, 2016 & 2026

Figure 123: Eastern Europe Biopsy Device Y-o-Y growth (%) By End Users, 2015–2026

Figure 124: Eastern Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Hospital Segment, 2016–2026

Figure 125: Eastern Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Specialized Oncology Center Segment, 2016–2026

Figure 126: Eastern Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Diagnostic centers Segment, 2016–2026

Figure 127: Eastern Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 128: Eastern Europe Biopsy Device Market Attractiveness Analysis By End Users, 2016–2026

Figure 129: APEJ Biopsy Device Y-o-Y growth (%) By Country, 2015–2026

Figure 130: APEJ Biopsy Device Y-o-Y growth (%) By Country, 2015–2026

Figure 131: APEJ Biopsy Device Market Attractiveness Analysis By Country, 2016–2026

Figure 132: APEJ Biopsy Device Market Share Analysis (%) By Product Type, 2016 & 2026

Figure 133: APEJ Biopsy Device Y-o-Y growth (%) By Product Type, 2015–2026

Figure 134: APEJ Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guidance System Segment, 2016–2026

Figure 135: APEJ Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Biopsy Needles Segment, 2016–2026

Figure 136: APEJ Biopsy Device Market Absolute $ Opportunity (US$ Mn) By guns Segment, 2016–2026

Figure 137: APEJ Biopsy Device Market Absolute $ Opportunity (US$ Mn) By reagents and kits Segment, 2016–2026

Figure 138: APEJ Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2016–2026

Figure 139: APEJ Biopsy Device Market Attractiveness Analysis By Product Type, 2016–2026

Figure 140: APEJ Biopsy Device Market Share Analysis (%) By Application, 2016 & 2026

Figure 141: APEJ Biopsy Device Y-o-Y growth (%) By Application, 2015–2026

Figure 142: APEJ Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Medical Diagnostic Segment, 2016–2026

Figure 143: APEJ Biopsy Device Market Absolute $  Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 144: APEJ Biopsy Device Market Attractiveness Analysis By Application, 2016–2026

Figure 145: APEJ Biopsy Device Market Share Analysis (%) By End Users, 2016 & 2026

Figure 146: APEJ Biopsy Device Y-o-Y growth (%) By End Users, 2015–2026

Figure 147: APEJ Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Hospital Segment, 2016–2026

Figure 148: APEJ Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Specialized Oncology Center Segment, 2016–2026

Figure 149: APEJ Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Diagnostic centers Segment, 2016–2026

Figure 150: APEJ Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 151: APEJ Biopsy Device Market Attractiveness Analysis By End Users, 2016–2026

Figure  152: Japan Biopsy Device Market Share Analysis (%) By Product Type, 2016 & 2026

Figure 153: Japan Biopsy Device Y-o-Y growth (%) By Product Type, 2015–2026

Figure 154: Japan Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guidance System Segment, 2016–2026

Figure 155: Japan Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Biopsy Needles Segment, 2016–2026

Figure 156: Japan Biopsy Device Market Absolute $ Opportunity (US$ Mn) By guns Segment, 2016–2026

Figure 157: Japan Biopsy Device Market Absolute $ Opportunity (US$ Mn) By reagents and kits Segment, 2016–2026

Figure 158: Japan Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2016–2026

Figure 159: Japan Biopsy Device Market Attractiveness Analysis By Product Type, 2016–2026

Figure 160: Japan Biopsy Device Market Share Analysis (%) By Application, 2016 & 2026

Figure 161: Japan Biopsy Device Y-o-Y growth (%) By Application, 2015–2026

Figure 162: Japan Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Medical Diagnostic Segment, 2016–2026

Figure 163: Japan Biopsy Device Market Absolute $  Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 164: Japan Biopsy Device Market Attractiveness Analysis By Application, 2016–2026

Figure 165: Japan Biopsy Device Market Share Analysis (%) By End Users, 2016 & 2026

Figure 166: Japan Biopsy Device Y-o-Y growth (%) By End Users, 2015–2026

Figure 167: Japan Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Hospital Segment, 2016–2026

Figure 168: Japan Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Specialized Oncology Center Segment, 2016–2026

Figure 169: Japan Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Diagnostic centers Segment, 2016–2026

Figure 170: Japan Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 171: Japan Biopsy Device Market Attractiveness Analysis By End Users, 2016–2026

Figure 172: MEA Biopsy Device Y-o-Y growth (%) By Country, 2015–2026

Figure 173: MEA Biopsy Device Y-o-Y growth (%) By Country, 2015–2026

Figure 174: MEA Biopsy Device Market Attractiveness Analysis By Country, 2016–2026

Figure 175: MEA Biopsy Device Market Share Analysis (%) By Product Type, 2016 & 2026

Figure 176: MEA Biopsy Device Y-o-Y growth (%) By Product Type, 2015–2026

Figure 177: MEA Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guidance System Segment, 2016–2026

Figure 178: MEA Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Biopsy Needles Segment, 2016–2026

Figure 179: MEA Biopsy Device Market Absolute $ Opportunity (US$ Mn) By guns Segment, 2016–2026

Figure 180: MEA Biopsy Device Market Absolute $ Opportunity (US$ Mn) By reagents and kits Segment, 2016–2026

Figure 181: MEA Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2016–2026

Figure 182: MEA Biopsy Device Market Attractiveness Analysis By Product Type, 2016–2026

Figure 183: MEA Biopsy Device Market Share Analysis (%) By Application, 2016 & 2026

Figure 184: MEA Biopsy Device Y-o-Y growth (%) By Application, 2015–2026

Figure 185: MEA Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Medical Diagnostic Segment, 2016–2026

Figure 186: MEA Biopsy Device Market Absolute $  Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 187: MEA Biopsy Device Market Attractiveness Analysis By Application, 2016–2026

Figure 188: MEA Biopsy Device Market Share Analysis (%) By End Users, 2016 & 2026

Figure 189: MEA Biopsy Device Y-o-Y growth (%) By End Users, 2015–2026

Figure 190: MEA Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Hospital Segment, 2016–2026

Figure 191: MEA Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Specialized Oncology Center Segment, 2016–2026

Figure 192: MEA Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Diagnostic centers Segment, 2016–2026

Figure 193: MEA Biopsy Device Market Attractiveness Analysis By End Users, 2016–2026

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate